GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

INSM · Jun 30, 2026

INSMED Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration

State dimensions

Filing0001104506-26-000041General Corporate
Debt relative to revenue5thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

128.50% · OPTIONAL · VALID

Capex intensity10thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.47% · OPTIONAL · VALID

Operating cash generation100thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-20.88% · OPTIONAL · VALID

Revenue growth100thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

296.11% · CORE · VALID

Inventory pressure20thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

33.46% · OPTIONAL · VALID

Operating margin100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

-0.36% · CORE · VALID

R&D intensity0thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

49.36% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

9.70% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History27 statesSelf-history eligible
Sep 30, 20217/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
178.70%
Current
128.50%
Delta
-50.20%
Capex Intensity Increased
Previous
1.14%
Current
1.47%
Delta
0.33%
Cash Generation Increased
Previous
-72.80%
Current
-20.88%
Delta
51.92%
Growth Increased
Previous
229.62%
Current
296.11%
Delta
66.49%
Inventory Pressure Decreased
Previous
43.44%
Current
33.46%
Delta
-9.98%
Profitability Increased
Previous
-50.11%
Current
-0.36%
Delta
49.75%
R And D Intensity Decreased
Previous
68.47%
Current
49.36%
Delta
-19.10%
Sbc Intensity Decreased
Previous
14.95%
Current
9.70%
Delta
-5.26%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Mar 31, 2026
Similarity
98%
Compared
8 dimensions
Coverage
100%
Growth 0.0 · Profitability 0.0 · Sbc Intensity 0.0 · Capex Intensity 5.0 · Cash Generation 0.0 · R And D Intensity 0.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 0.0
Sep 30, 2025
Similarity
70%
Compared
8 dimensions
Coverage
100%
Growth 0.0 · Profitability 80.0 · Sbc Intensity 15.0 · Capex Intensity 5.0 · Cash Generation 20.0 · R And D Intensity 10.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 5.0
Dec 31, 2020
Similarity
68%
Compared
7 dimensions
Coverage
88%
Profitability 37.5 · Sbc Intensity 37.5 · Capex Intensity 2.5 · Cash Generation 12.5 · R And D Intensity 62.5 · Inventory Pressure 7.5 · Balance Sheet Leverage 5.0
Jun 30, 2022
Similarity
62%
Compared
8 dimensions
Coverage
100%
Growth 20.0 · Profitability 14.3 · Sbc Intensity 21.4 · Capex Intensity 40.0 · Cash Generation 28.6 · R And D Intensity 50.0 · Inventory Pressure 51.4 · Balance Sheet Leverage 52.1
Dec 31, 2021
Similarity
52%
Compared
8 dimensions
Coverage
100%
Growth 50.0 · Profitability 58.3 · Sbc Intensity 41.7 · Capex Intensity 23.3 · Cash Generation 66.7 · R And D Intensity 75.0 · Inventory Pressure 3.3 · Balance Sheet Leverage 11.7
Research Graph

Related governed research

Analogous To · INSM state analogue 2 →Analogous To · INSM state analogue 3 →Analogous To · INSM state analogue 5 →Analogous To · INSM state analogue 1 →Compared To · Pharmaceutical Preparations peers →Analogous To · INSM state analogue 4 →Derived From · INSM Company Quality Vector →Has State · INSMED Inc →Transitioned To · INSM Fundamental State →Transitioned To · INSM BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · INSM CAPEX_INTENSITY_INCREASED →Transitioned To · INSM CASH_GENERATION_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.